Hot Pursuit     14-Jan-25
Fischer Medical gains as arm gets license from CDSCO to make MRI machines
Fischer Medical Ventures advanced 2.25% to Rs 719 after its wholly owned subsidiary, Time Medical International Ventures (India) received license from Central Drugs Standard Control Organization (CDSCO) to manufacture MRI systems.
Time Medical International Ventures (India) has become the first Magnetic Resonance Imaging (MRI) manufacturer in India to receive the official license to manufacture for sale or distribution of Magnetic Resonance Diagnostic Devices (MRDD) from the CDSCO.

With this new license, Time Medical will manufacture and distribute the following MRI systems, some of which are FDA and CE approved as well, ensuring compliance with global safety, quality, and regulatory standards: EMMA - 1.5T MRI Scanner, PICA - 0.35T MRI Scanner, MICA - 1.5T MRI Scanner and QUIN - 1.5T MRI Scanner.

The EMMA, MICA, and QUIN MRI systems are 1.5T MRI scanners, offering exceptional imaging resolution and precision for a wide range of clinical applications, while the PICA model is a 0.35T MRI scanner, tailored for specific diagnostic needs. These models are available for distribution across India, helping to address the growing demand for reliable and advanced medical imaging solutions.

"We are thrilled to be the first Make in India company to receive the CDSCO license for the manufacturing and distribution of MRI systems. This achievement demonstrates the strength and potential of India's medical device manufacturing sector. With our EMMA, PICA, MICA, and QUIN MRI systems, we are committed to providing hospitals and diagnostic centers with cutting-edge, affordable diagnostic imaging solutions,” said the Management Team of Fischer Medical Ventures.

Fischer Medical Ventures has changed the nature of Business from Manufacturing of Chemicals to Trading and Manufacturing of Medical equipment including MRI machines consequent to share subscription agreement.

The company reported consolidated net profit of Rs 0.29 crore in Q2 FY25 as against net loss of Rs 0.12 crore in Q1 FY25. Net sales surged 291.9% YoY to Rs 39.66 crore in the September 2024 quarter.

Previous News
  Fischer Chemic reports standalone net profit of Rs 0.05 crore in the September 2018 quarter
 ( Results - Announcements 18-Nov-18   09:51 )
  Fischer Medical Ventures partners with Singapore-based Nervotec
 ( Corporate News - 01-Jul-24   19:29 )
  Fischer Chemic reports standalone net loss of Rs 0.05 crore in the September 2017 quarter
 ( Results - Announcements 13-Dec-17   16:10 )
  Fischer Chemic standalone net profit rises 400.00% in the March 2024 quarter
 ( Results - Announcements 31-May-24   07:38 )
  Fischer Chemic announces board meeting date
 ( Corporate News - 05-Aug-21   09:50 )
  Fischer Chemic reports net loss of Rs 0.03 crore in the March 2010 quarter
 ( Results - Announcements 03-May-10   16:24 )
  Fischer Chemic schedules board meeting
 ( Corporate News - 03-Aug-22   20:01 )
  Fischer Chemic AGM scheduled
 ( Corporate News - 31-Aug-23   14:23 )
  Fischer Chemic reports standalone net loss of Rs 0.03 crore in the December 2015 quarter
 ( Results - Announcements 15-Feb-16   09:39 )
  Fischer Chemic to hold board meeting
 ( Corporate News - 24-Sep-15   17:40 )
  Fischer Chemic reports standalone net loss of Rs 0.05 crore in the June 2017 quarter
 ( Results - Announcements 14-Sep-17   10:03 )
Other Stories
  Cupid Q3 PAT jumps 25% to Rs 11 cr
  15-Feb-25   15:46
  AGS Transact Tech Q3 net loss widens to Rs 194 cr
  15-Feb-25   15:04
  Swan Energy Q3 PAT soars 406% YoY to Rs 583 cr
  15-Feb-25   12:45
  Genesys Intl Q3 PAT climbs 32% YoY to Rs 21 cr
  15-Feb-25   12:15
  PTC Industries Q3 PAT spurts 76% YoY to Rs 14 cr
  15-Feb-25   11:34
  RVNL Q3 PAT slides 13% YoY to Rs 311 crore
  15-Feb-25   10:47
  BHEL bags Rs 6,700 crore power project from Singareni Collieries
  15-Feb-25   09:48
  Mahindra & Mahindra's electric SUVs see 30,179 bookings on day 1
  15-Feb-25   09:32
  Reliance Industries acquires Lakadia B Power Transmission
  15-Feb-25   09:21
  Ethos rises after Q3 PAT climbs 15% YoY to Rs 29 cr
  14-Feb-25   15:12
Back Top